Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Public Health

Background:

• Staphylococcus aureus is a significant human pathogen.
• Methicillin-resistant S. aureus (MRSA) presents a growing challenge due to antibiotic resistance.
• Understanding the epidemiology of community-acquired S. aureus is crucial for effective management.

Purpose of the Study:

• To compare clinical features and antibiotic sensitivity of multiresistant and non-multiresistant MRSA and methicillin-sensitive S. aureus (MSSA) isolates.
• To identify characteristics associated with different S. aureus strains in a community setting.
• To inform clinical practice regarding the diagnosis and treatment of S. aureus infections.

Main Methods:

• Retrospective case series of patients presenting to hospital departments.
• Inclusion of all MRSA cases and the first 100 MSSA cases over a one-year period.
• Analysis of patient demographics, risk factors, clinical presentation, treatment, outcome, and isolate antibiotic susceptibility.

Main Results:

• Of 122 patients, 8% had multiresistant MRSA, 21% non-multiresistant MRSA, and 70% MSSA.
• A higher proportion of non-multiresistant MRSA patients were born in New Zealand, Samoa, or Tonga (29%).
• Nearly half of non-multiresistant MRSA strains were community-acquired without risk factors; cellulitis and abscess were common presentations.

Conclusions:

• Non-multiresistant MRSA strains are prevalent, frequently community-acquired, and disproportionately affect individuals from specific Pacific Island nations.
• Clinical suspicion and routine swabbing of staphylococcal lesions for culture and sensitivity testing are essential.
• This highlights the need for targeted public health strategies and antibiotic stewardship.